Role of Recombinants in Peach Allergy

NCT00715156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2012-02-22

No results posted yet for this study

Summary

This study is aimed at verifying the role and the efficacy of the recombinants allergens Pru p 1, Pru p 3 and Pru p 4, Bet v 1, Bet v 2 and Bet v 4 in the diagnosis of peach allergy

Conditions

Sponsors & Collaborators

  • Niguarda Hospital

    lead OTHER

Principal Investigators

  • Elide A Patorello, MD · Niguarda Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-10-31
Completion
2010-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00715156 on ClinicalTrials.gov